Featured Research

from universities, journals, and other organizations

Analysis indicates a third H1N1 pandemic wave unlikely in 2010

Date:
October 19, 2010
Source:
Canadian Medical Association Journal
Summary:
Analysis of H1N1 antibody levels (seroprotection rates) after the 2009 pandemic suggest that a third wave is unlikely in 2010, although adults over age 50, particularly those with chronic conditions, should be immunized for the fall flu season, states a research article.

Analysis of H1N1 antibody levels (seroprotection rates) after the 2009 pandemic suggest that a third wave is unlikely in 2010, although adults over age 50, particularly those with chronic conditions, should be immunized for the fall flu season, states a research paper in CMAJ (Canadian Medical Association Journal).

The study, by researchers from the BC Centre for Disease Control, University of British Columbia and BC Biomedical Laboratories, compared blood levels of antibodies against the H1N1 influenza before and after the 2009 pandemic. They looked at 1127 people in British Columbia's Lower Mainland aged 9 months to 101 years.

Samples collected before the pandemic indicated that less than 10% of children and adults under age 70 had protective levels of H1N1 antibodies whereas 77% of people over age 80 had protective levels. In follow up after the waves of infection and the fall 2009 immunization campaign, the researchers found a 70% protection rate in people under age 20 but lower seroprotection rates in adults aged 20-49 (44%) and 50-79 years of age (30%). People aged 70-79 years had the lowest rate of antibodies (21%) whereas those over 80 years had higher rates.

"The higher percentage with seroprotection we observed in the young may have resulted from higher pandemic H1N1 infection rates and earlier prioritization of pandemic H1N1 vaccine to young children," writes Dr. Danuta Skowronski, BC Centre for Disease Control and University of British Columbia with coauthors.

They estimate that a community-level protection above 40% would be enough to prevent a large epidemic in a population, especially if school-age children who generally contribute most to the spread of influenza are protected. Given that the overall seroprotection rate is estimated at 46% and 70% in school-age children, "these findings reassure against the likelihood of a substantial third pandemic H1N1 wave during the 2010-11 season, unless there is a significant waning of antibody or change in the virus" the authors state.

"Adults 50-79 years exhibited the lowest seroprotection and also remain at higher risk of severe outcomes if infected," they caution. "Our findings support a shift from the prioritized immunization of the young that occurred in fall 2009 to prioritized immunization of older adults for the coming 2010-11 influenza season to protect against severe outcomes due to both pandemic and seasonal influenza."


Story Source:

The above story is based on materials provided by Canadian Medical Association Journal. Note: Materials may be edited for content and length.


Journal Reference:

  1. Danuta M. Skowronski, Travis S. Hottes, Naveed Z. Janjua, Dale Purych, Suzana Sabaiduc, Tracy Chan, Gaston De Serres, Jennifer Gardy, Janet E. Mcelhaney, David M. Patrick, Martin Petric. Prevalence of seroprotection against the pandemic (H1N1) virus after the 2009 pandemic. Canadian Medical Association Journal, October 18, 2010 DOI: 10.1503/cmaj.100910

Cite This Page:

Canadian Medical Association Journal. "Analysis indicates a third H1N1 pandemic wave unlikely in 2010." ScienceDaily. ScienceDaily, 19 October 2010. <www.sciencedaily.com/releases/2010/10/101018121352.htm>.
Canadian Medical Association Journal. (2010, October 19). Analysis indicates a third H1N1 pandemic wave unlikely in 2010. ScienceDaily. Retrieved September 18, 2014 from www.sciencedaily.com/releases/2010/10/101018121352.htm
Canadian Medical Association Journal. "Analysis indicates a third H1N1 pandemic wave unlikely in 2010." ScienceDaily. www.sciencedaily.com/releases/2010/10/101018121352.htm (accessed September 18, 2014).

Share This



More Health & Medicine News

Thursday, September 18, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

The Cost of Ebola

The Cost of Ebola

Reuters - Business Video Online (Sep. 18, 2014) As Sierra Leone prepares for a three-day "lockdown" in its latest bid to stem the spread of Ebola, Ciara Lee looks at the financial implications of fighting the largest ever outbreak of the disease. Video provided by Reuters
Powered by NewsLook.com
What HealthKit Bug Means For Your iOS Fitness Apps

What HealthKit Bug Means For Your iOS Fitness Apps

Newsy (Sep. 18, 2014) Apple has delayed the launch of the HealthKit app platform, citing a bug. Video provided by Newsy
Powered by NewsLook.com
Residents Vaccinated as Haiti Fights Cholera Epidemic

Residents Vaccinated as Haiti Fights Cholera Epidemic

AFP (Sep. 18, 2014) Haitians receive the second dose of the vaccine against cholera as part of the UN's vaccination campaign. Duration: 00:34 Video provided by AFP
Powered by NewsLook.com
Raw: Elephant Undergoes Surgery in Tbilisi Zoo

Raw: Elephant Undergoes Surgery in Tbilisi Zoo

AP (Sep. 18, 2014) Grand the elephant has successfully undergone surgery to remove a portion of infected tusk at Tbilisi Zoo in Georgia. British veterinary surgeons used an electric drill to extract the infected piece. (Sept. 18) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins